Mammazentrum Hamburg MVZ GbR
Hospital
Location:
Hamburg,
Germany (DE)
ISNI: -
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial (2018)
Stevic I, Mueller V, Weber K, Fasching P, Karn T, Marme F, Schem C, et al.
Journal article
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto (2018)
Loibl S, Weber KE, Timms KM, Elkin EP, Hahnen E, Fasching P, Lederer B, et al.
Journal article